An Extended Model of Reasoned Action to Understand the Influence of Individual- and Network-Level Factors on African Americans’ Participation in HIV Vaccine Research
In the United States, the number and proportion of HIV/AIDS cases among black/African Americans continue to highlight the need for new biomedical prevention interventions, including an HIV vaccine, microbicide, or new antiretroviral (ARV) prevention strategies such as pre-exposure prophylaxis (PrEP) to complement existing condom usage, harm reduction methods, and behavioral change strategies to stem the HIV epidemic. Although black/African Americans are disproportionately impacted by HIV/AIDS, their participation in HIV clinical research continues to have unique challenges. We theorize that interaction among multilevel factors creates ideal alignment for minority participation in HIV clinical studies. Thus, we initially set out to test an extended model of reasoned action with 362 participants to understand the interplay of sociopsychological and network-level considerations influencing minority participation in HIV prevention research efforts. In this study, we linked the intrapersonal dimensions of attitudes, beliefs, and normative concerns to community-level components, appraisal of involvement with the clinical research organization, an entity which operates within a networked structure of community partner agencies, and identification with coalition advocacy aims. Various participatory outcomes were explored including involvement in future HIV vaccine community functions, participation in community promotion of HIV vaccine research, and community mobilization. Three-stage least squares estimates indicated similar findings across three models. Significant effects demonstrate the importance of positive attitudes toward HIV vaccine research, favorable health research beliefs, perceived social support for participation, HIV/AIDS issue engagement, and perceived relevance of the clinical research site’s mission and values. Identification of these nuanced pathway effects provides implications for tailored community program development.
KeywordsHIV/AIDS HIV vaccine African Americans Community engagement Willingness to participate
The authors wish to thank Hannah Cooper, ScD, Emory University and Emily Bass, AIDS Vaccine Advocacy Coalition (AVAC) for scientific and editorial review, the APRCC members for their support of this study, and our anonymous reviewers for excellent comments and suggestions.
- AIDS Vaccine Advocacy Coalition. (2008). Anticipating the results of PrEP trials: A powerful new HIV prevention tool may be on the horizon. Are we prepared? Retrieved September 24, 2008, from http://www.avac.org/prep08.pdf.
- Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting behavior. Englewood Cliffs, NJ: Prentice-Hall.Google Scholar
- Black AIDS Institute. (2008). Left behind: black America: A neglected priority in the global AIDS epidemic. Retrieved August 12, 2008, from http://www.blackaids.org.
- Bollen, K. A. (2001). Two-stage least squares and latent variable models: Simultaneous estimation and robustness to misspecifications. In R. Cudeck, S. D. Toit, & D. Sorbom (Eds.), Structural equation modeling: Present and future. A Festschrift in Honor of Karl Joreskog (pp. 119–138). Lincoln, NC: Scientific Software.Google Scholar
- Brown, T. A. (2006). Confirmatory factor analysis for applied research (1st ed.). New York: Guilford.Google Scholar
- Centers for Disease Control and Prevention. (2007a). HIV/AIDS surveillance report. Rev ed (Vol. 17, pp. 1–54). Atlanta, GA: US Department of Health and Human Services.Google Scholar
- Centers for Disease Control and Prevention. (2007b). Rapid HIV testing in outreach and other community settings—United States, 2004–2006. Morbidity and Mortality Weekly, 56, 1233–1237.Google Scholar
- Centers for Disease Control and Prevention. (2008). HIV/AIDS surveillance supplemental report: Cases of HIV infection and AIDS in the United States and dependent areas, by race/ethnicity, 2002–2006. Retrieved September 25, 2008, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2008supp_vol13no1/pdf/HIVAIDS_SSR_Vol13_No1.pdf.
- Davis, C., & Randhawa, G. (2006). The influence of religion on organ donation and transplantation among the Black Caribbean and Black African population—a pilot study in the United Kingdom. Ethnicity & Disease, 16, 281–285.Google Scholar
- Fishbein, M., & Ajzen, I. (1975). Belief, attitude, intention, and behavior. Menlo Park, CA: Addison-Wesley.Google Scholar
- Frew, P. M., Archibald, M., Martinez, N., del Rio, C., & Mulligan, M. (2008a). Promoting HIV vaccine research in the African American community: Does the theory of reasoned action explain potential outcomes of involvement? Challenge: The Journal of the Morehouse Research Institute, 13, 61–97.Google Scholar
- Frew, P. M., Crosby, R. A., Salazar, L. F., Gallinot, L., Bryant, L. O., & Holtgrave, D. R. (2008b). Acceptance of an HIV/AIDS vaccine among minority women. Journal of the National Medical Association, 100, 802–813.Google Scholar
- Fuchs, J., Durham, M., McLellan-Lemal, E., Vittinghoff, E., Colfax, G., Gurwith, M., et al. (2007). Negative social impacts among volunteers in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 47, 1–7.Google Scholar
- Gagnon, M. P., & Godin, G. (2000). Young adults and HIV vaccine: Determinants of intention of getting immunized. Canadian Journal of Public Health, 91, 432–434.Google Scholar
- Gibbons, F. X. (2008). Health behavior constructs: Theory, measurement & research (Intention, Expectation, and Willingness). Retrieved January 16, 2009, from http://cancercontrol.cancer.gov/brp/constructs/intent-expect-willingness/index.html.
- HIV Prevention Trials Network. (2008). Community participation. Retrieved June 24, 2008, from www.hptn.org/community_program/community_participation.htm.
- Kline, R. B. (2005). Principles and practice of structural equation modeling (2nd ed.). New York: Guilford.Google Scholar
- Leventhal, H., Brissette, I., & Leventhal, E. A. (2003). The common-sense model of self-regulation of health and illness. In L. D. Cameron & H. Leventhal (Eds.), The self-regulation of health and illness behaviour (pp. 42–65). London, UK: Routledge.Google Scholar
- McKnight, P. E., McKnight, K. M., Sidani, S., & Figueredo, A. J. (2007). Missing data: A gentle introduction. New York: Guilford.Google Scholar
- Meyers, L. S., Gamst, G., & Guarino, A. J. (2006). Applied multivariate research: Design and interpretation. Thousand Oaks, CA: Sage.Google Scholar
- National Medical Association. (2001). Recommendation of the clinical trials consensus panel. Journal of the National Medical Association, 92, 464–471.Google Scholar
- National Minority AIDS Council. (2008). AIDS crisis in communities of color prompts demand for national AIDS plan. Retrieved August 31, 2008, from http://www.nmac.org/index/news-app/story.55/title.aids-crisis-in-communities-of-color-prompts-demand-for-national-aids-plan-read-press-release-and-position-paper.
- Prejean, J., Song, R., An, Q., & Hall, H. (2008). Subpopulation estimates from the HIV incidence surveillance system—United States, 2006. Morbidity and Mortality Weekly, 57, 985–989.Google Scholar
- Rossi, L. (2008). HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study: Getting inside the cells and minds of women: Trial looks at drug absorption and adherence of different formulations of tenofovir. Retrieved July 17, 2008, from http://www.mtnstopshiv.org/node/462.
- Southern States AIDS Directors Work Group. (2008). Southern states manifesto: Update 2008—HIV/AIDS and sexually transmitted diseases in the South. Retrieved September 25, 2008, from http://southernaidscoalition.org/Manifesto%20Update%20Final%20pdf%20071408.pdf.
- UNAIDS, & AIDS Vaccine Advocacy Coalition. (2007). Good participatory practice: Guidelines for biomedical HIV prevention trials. Geneva, Switzerland.Google Scholar